GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioRestorative Therapies Inc (FRA:9OF) » Definitions » Additional Paid-In Capital

BioRestorative Therapies (FRA:9OF) Additional Paid-In Capital : €154.61 Mil(As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is BioRestorative Therapies Additional Paid-In Capital?


BioRestorative Therapies's quarterly additional paid-in capital increased from Sep. 2024 (€147.78 Mil) to Dec. 2024 (€156.81 Mil) but then stayed the same from Dec. 2024 (€156.81 Mil) to Mar. 2025 (€154.61 Mil).

BioRestorative Therapies's annual additional paid-in capital increased from Dec. 2022 (€138.35 Mil) to Dec. 2023 (€143.68 Mil) and increased from Dec. 2023 (€143.68 Mil) to Dec. 2024 (€156.81 Mil).


BioRestorative Therapies Additional Paid-In Capital Historical Data

The historical data trend for BioRestorative Therapies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRestorative Therapies Additional Paid-In Capital Chart

BioRestorative Therapies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.76 137.82 138.35 143.68 156.81

BioRestorative Therapies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.34 152.11 147.78 156.81 154.61

BioRestorative Therapies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

BioRestorative Therapies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of BioRestorative Therapies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRestorative Therapies Business Description

Traded in Other Exchanges
Address
40 Marcus Drive, Suite One, Melville, NY, USA, 11747
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

BioRestorative Therapies Headlines

No Headlines